Transcript CCG authorisation slides

Principles previously agreed
 Towards Authorisation (published 30/09/11) sets out thinking to date and some key
parameters:
Authorisation:
design for success
Assuming the majority of CCGs will be authorised by April 2013.
Expecting that 100% are established with conditions where appropriate.
Authorisation
as a journey
Recognising authorisation as a safe threshold on a journey of continuous improvement, not
an end point. A maturity model.
Potential after
authorisation
Seeing authorisation as an assessment of confidence in CCGs’ potential to deliver, whilst
also drawing on track record to date as delegated sub-committees of PCTs
6 domains of
authorisation
Describing a good clinical commissioning group through the domains is enjoying significant
support as a simple framework easily understood
Evidence for
authorisation
Minimising the evidence requirement for formal submission of evidence.
Maximising the use of the pre-authorisation period for informal submission.
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
1
Authorisation remains based on six domains as widely discussed
1
A strong clinical and multi-professional focus which brings real added value
2
Meaningful engagement with patients, carers and their communities
3
Clear and credible plans which continue to deliver the QIPP challenge within
financial resources, in line with national requirements (including outcomes) and
local joint health and wellbeing strategies
4
Proper constitutional and governance arrangements, with the capacity and
capability to deliver all their duties and responsibilities, including financial
control, as well as effectively commission all the services for which they are
responsible
5
Collaborative arrangements for commissioning with other clinical
commissioning groups, local authorities and the NHS Commissioning Board as
well as the appropriate external commissioning support
6
Great leaders who individually and collectively can make a real difference
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
Authorisation content: a clear line of sight
Potential beyond
authorisation
Criteria
Threshold for
authorisation
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
Evidence for
authorisation
Draft application submission list
 Authorisation application form
 CCG constitution and other documents detailing governance arrangements (please specify)
 CCG Organogram
 Case studies (please specify)
 Draft Joint Strategic Needs Assessment
 Financial management arrangements compliant with national requirements
 Health and Wellbeing Board minutes and reports
 Joint Health and Wellbeing Strategy
 Letter of support for CCG Chair
 List of collaborative and joint commissioning arrangements
 Minutes of multi-professional meetings
 Organisational Development Plan
 SLA or MoU with assured commissioning support provider
 2012-13 contracts
 2012-13 Integrated Plan and draft commissioning intentions for 2013-14
 360° stakeholder survey report and CCG comment
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
Phases of Authorisation
Pre-application
Application
Covering:
•Most aspects of
governance
•Organisational form
•Commissioning
support arrangements
Enabling the
CCG to set out
factual details
relevant to its
application, but
also to
demonstrate
compliance /
self-certify
against a
number of
authorisation
criteria
NHSCB assessment
Covering all
aspects of
authorisation
•Desktop review
•360 review
•Site visit
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
CCG performance and population health profiles
 Provided to all CCGs at least one month before the application date for their wave, profiles will
provide the following data configured at CCG level:
• Geography - including the relationship between the CCG and their Local Authority, and the
relationship between a CCG’s registered and resident population;
• Demographic and socioeconomic profile - e.g. age/ sex/ Index of Multiple Deprivation;
• Population level outcomes data - e.g. QOF;
• Activity and outcomes data (e.g. the latter from inpatient survey) split by main provider;
• Performance data;
• Finance - including baselines, fairshares and risk of overspend given the CCG populations.
 CCG profiles will be used by the assessor team to understand the challenges facing applicant
CCGs and will form part of the data triangulation on track record, planning, prioritisation and
financial management.
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
360° Stakeholder Review
Objective
The survey will assess whether CCGs have been developing strong foundations for successful
relationships with all key stakeholders and examine the potential for these relationships to evolve
evolve.
Participants
c40-45 stakeholders per CCG to include GP constituent practices, other CCGs, (shadow) Heath
& Wellbeing boards, Local Authorities, LINks/(shadow) Healthwatch, NHS providers…
Timing
CCGs to provide participants’ contact details approx. 8 weeks prior to authorisation. Survey
results will be returned to CCGs just prior to authorisation leaving enough time for their comment
Format
An online survey that will include generic questions to all participants plus small banks of
stakeholder-specific questions. Total survey length will be approx. 15-20 mins
Content
Will cover themes such as stakeholders’ experiences of working with emerging CCGs so far and
their opinions of CCGs’ potential to deliver quality, clinically-led commissioning in the future
Role of CCGs
To provide accurate stakeholder contact in a timely manner and to submit the survey results plus
CCG comments as part of the authorisation documentation
Assistance provided
Information materials and a website will help inform CCGs and their stakeholders as to the
survey’s purpose and content. A dedicated email and enquiry line will also be made available
Non-response
Non-respondents will be followed up with reminder emails and a phone call. Any stakeholders not
wishing to participate in the full survey will be asked to complete a non-response survey
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
Case Studies
 CCGs are asked to submit case studies as part of their application, and they will also be used to
establish a national library of best practice emerging from clinical commissioning
 They are an opportunity for CCGs to demonstrate their ability to deliver improvements (e.g. in
access to services, health outcomes, service quality/productivity, reducing health inequalities)
across all six domains. They also form part of the core evidence for authorisation in the following
areas:
• Member practice involvement in decision-making
• Taking devolved responsibility for specific commissioning budgets/areas/programmes from local PCT
cluster
• Innovation - e.g. through use of intelligence/information, service redesign, through collaboration with
other clinicians, engagement with the public and patients, use of technology
• Leadership and leadership development
• Enhanced clinical involvement in service redesign and improvement
• Involvement in 2012-13 contracting round
• Measurable improvements in productivity and quality delivered – e.g. improved holistic management
of patients with chronic conditions and those at end of life
• Engaging different groups and communities through a range of communications channels in the
development of vision, commissioning plan, or in broader CCG decision-making processes
• CCG collaboration with other CCGs and a multi-disciplinary range of clinicians
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION
Application Timetable
COMMISSIONING DEVELOPMENT PROGRAMME
WORK IN PROGRESS – STRICTLY NOT FOR FURTHER CIRCULATION